SCVI2149C1

General

Cell Line

hPSCreg name SCVIi061-A
Cite as:
SCVIi061-A (RRID:CVCL_C1S8)
Alternative name(s)
SCVI2149C1
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
SCVIi062-A
(SCVI2150c1)
Donor diseases:
Long QT Syndrome
ITXi004-A
(MS381)
Donor diseases:
Long QT Syndrome
YUCMi022-A
(hiPSC-KCNH2_G53S)
Donor diseases:
Long QT Syndrome
ITXi003-A
(MS368)
Donor diseases:
Long QT Syndrome
ZJUi010-A
(ZJULLi002-A, 161103SPYLQTFSDC12)
Donor diseases:
Long QT Syndrome
ISMMSi046-A
(PLN-R14del-3BC7)
Donor diseases:
Cardiomyopathy
SCVIi073-A
(SCVIi574C2)
Donor's gene variants:
titin, BAG cochaperone 3, BAG cochaperone 3
Donor diseases:
Dilated Cardiomyopathy
SCVIi074-A
(SCVIi599C1)
Donor's gene variants:
BAG cochaperone 3
Donor diseases:
Hypertrophic Cardiomyopathy
PUMCHi002-A
(20180908R-AE3, PUMCH-IRC)
Donor diseases:
Restrictive Cardiomyopathy
FAMRCi006-A
(LMNA T3)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
FAMRCi006-B
(LMNA T4)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
UKKi031-A
(NP0138-8B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-B
(NP0138-19E)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-C
(NP0138-31B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
USFi003-A
(1AB1)
Donor diseases:
Dilated Cardiomyopathy
FAMRCi010-A
(RCMP48)
Donor's gene variants:
FLNC
Donor diseases:
Restrictive Cardiomyopathy
UKKi025-A
(NP0135-1)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
ICGi029-A
(HCM14fm6.2)
Donor diseases:
Hypertrophic Cardiomyopathy
IBBISTi006-A
(F93 clone 5)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi017-B
(NP0075-10K)
Donor diseases:
Rare hypertrophic cardiomyopathy
IBBISTi006-B
(F93 clone 6)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi017-C
(NP0075-11B)
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi025-B
(NP0135-2)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi025-C
(NP0135-7)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
ISCRMi001-A
(3-0062, DSP Leu462fs)
Donor diseases:
Inherited arrhythmogenic cardiomyopathy
ISMMSi044-A
(PLNR14del-1BC1)
Donor diseases:
Cardiomyopathy
ISMMSi045-A
(PLNR14del-2BC4)
Donor diseases:
Cardiomyopathy
ISMMSi047-A
(PLN-R14del-4AC4)
Donor diseases:
Cardiomyopathy
ISMMSi048-A
(PLN-R14del-5BC4)
Donor diseases:
Cardiomyopathy
SCVIi037-A
(SCVI672)
Donor diseases:
hypertrophic cardiomyopathy
Last update 26th September 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Stanford Cardiovascular Institute (SCVI)

External Databases

BioSamples SAMEA110250528
Cellosaurus CVCL_C1S8
Wikidata Q114312975

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex female
Ethnicity Asian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Ventricular arrhythmia associated with long QT syndrome
  • Long QT Syndrome
  • LONG QT SYNDROME

External Databases (Donor)

BioSamples SAMEA111396667

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Please provide contact information of the holder of the original Donor Information Sheet. joewu@stanford.edu
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. anonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? The generation of the lines was approved by the Administrative Panel on Human Subjects Research (IRB) under IRB #29904 “Derivation of Human Induced Pluripotent Stem Cells (Biorepository)
Approval number IRB #29904
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
Yes
Methods used
RT-PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
CO2 Concentration 5 %
Medium Other medium:
Base medium: StemMACS™ iPS-Brew XF
Main protein source:
Serum concentration: %

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
SOX2
Yes
Score:
Marker Present Absent
mCpG
OCT4
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
SOX17
Yes
FOXA2
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
Brachyury
Yes
TBX6
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
OTX2
Yes
pax6
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
KaryoStat+ analysis

Other Genotyping (Cell Line)